Volume 23 - Issue 3 - March 2015
Department
Anomalies
02/26/2015
Ioannis Parastatidis, MD, PhD*, Kunal Bhatt, MD*, Bernetta M. Howard, BSN, RN-BC, CCRN‡, Leon Rubinsztain, MD†, and Andro Kacharava, MD, PhD*, ‡
Ioannis Parastatidis, MD, PhD*, Kunal...
A 61-year-old man with multiple risk factors underwent cardiac catheterization for evaluation of chest pain and a small reversible anterior/anterolateral wall defect on an exercise myocardial perfusion imaging.
A 61-year-old man with multiple risk factors underwent cardiac catheterization for evaluation of chest pain and a small reversible anterior/anterolateral wall defect on an exercise myocardial perfusion imaging.
A 61-year-old man with multiple...
02/26/2015
Cath Lab Digest
Column
Case Files by Dr. George
02/26/2015
Frank Amico, DO, Vincent Varghese, DO, and Jon C. George, MD, Division of Interventional Cardiology and Endovascular Medicine, Deborah Heart and Lung Center, Browns Mills, New Jersey
Frank Amico, DO, Vincent Varghese, DO...
A 48-year-old male with paroxysmal atrial fibrillation presented for a left atrial appendage closure secondary to contraindication to oral anticoagulation. The closure was performed successfully using the Lariat suture-based closure system...
A 48-year-old male with paroxysmal atrial fibrillation presented for a left atrial appendage closure secondary to contraindication to oral anticoagulation. The closure was performed successfully using the Lariat suture-based closure system...
A 48-year-old male with...
02/26/2015
Cath Lab Digest
Feature
Case Report
02/26/2015
John K. Forrest, MD, Director Structural Heart Disease Program, Abeel A. Mangi, MD, Surgical Director Transcatheter Therapies, Michael Cleman, MD, Director of Cardiac Cath Lab, Yale New Haven Hospital New Haven, Connecticut
John K. Forrest, MD, Director Structu...
The CoreValve is the first transcatheter valve to have shown superiority to surgical aortic valve replacement for in patients with increased surgical risk. The following case study illustrates the effective use of this valve in a high-risk...
The CoreValve is the first transcatheter valve to have shown superiority to surgical aortic valve replacement for in patients with increased surgical risk. The following case study illustrates the effective use of this valve in a high-risk...
The CoreValve is the first...
02/26/2015
Cath Lab Digest
02/26/2015
This month, Cath Lab Digest would like to congratulate…
This month, Cath Lab Digest would like to congratulate…
This month, Cath Lab Digest...
02/26/2015
Cath Lab Digest
Your Path to Success: Expert Advice
02/26/2015
Susan N. Heck, Senior Vice President, Corazon, Inc., Pittsburgh, Pennsylvania
Susan N. Heck, Senior Vice President,...
For cardiovascular (CV) program administrators, there are three particular areas of regulatory change that may significantly impact program performance and overall organizational success: value-based purchasing, 30-day readmission penalties,...
For cardiovascular (CV) program administrators, there are three particular areas of regulatory change that may significantly impact program performance and overall organizational success: value-based purchasing, 30-day readmission penalties,...
For cardiovascular (CV) program...
02/26/2015
Cath Lab Digest
